Cytomegalovirus in
Hematopoietic Stem Cell Transplant Recipients.
'Half-matched
hematopoietic stem cell transplants usually elicit strong rejection from the recipient's body,' said Wang, director of the hospital's hematology department.
Aljurf, Establishing a
Hematopoietic Stem Cell Transplant Unit: A Practical Guide, Springer, 2017.
Hematopoietic stem cell transplant [HSCT] recipients have a high risk of acquiring invasive fungal infection [IFI] by virtue of prolonged myelosuppression.1 Mucormycosis is a devastating invasive fungal disease whose incidence has increased during the past decade.2,3 This mold belongs to the order Mucorales, which includes Mucor, Rhizopus, and Absidia.4-6
Allogeneic
hematopoietic stem cell transplant patients are at high risk of complications and recurrent hospitalizations.
Pelletier, "Pediatric sibling donors of successful and unsuccessful
hematopoietic stem cell transplants (HSCT): a qualitative study of their psychosocial experience," Journal of Pediatric Psychology, vol.
HSC835 is a novel cell therapy approach then enables an expanded single umbilical cord blood derived
hematopoietic stem cell transplant in patients with limited treatment options.
"Treatments such as hydroxyurea therapy, blood transfusion therapy and surgical management,
hematopoietic stem cell transplant, opiate detoxification and rehabilitation will also be addressed."
Hortobagyi also conducted one of the earliest randomized trials testing high-dose chemotherapy and autologous
hematopoietic stem cell transplant in primary breast cancer.
The companies expect to initiate the Phase 3 trial of TransVax(TM) for
hematopoietic stem cell transplant (HSCT) recipients in the second half of 2012, and initiate a Phase 2 efficacy trial of TransVax(TM) for solid organ transplant (SOT) recipients shortly thereafter.
Brian received an allogeneic
hematopoietic stem cell transplant for acute myelogenous leukemia seven weeks ago.
Washington, Oct 31 (ANI): A new study has revealed that targeted immunotherapy has been found effective in treating lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a
hematopoietic stem cell transplant (HSCT).